Further studies an antoclaved cercarial vaccine against Schistosomasis: Safety, longevity and stability

ABSTRACT

This study was performed to adjust the dose and to assess vaccine safety, longevity and stability as well as the possibility of transplacental transmission of immune response from pregnant mice to their offspring. The results showed that two doses of the lowest most effective concentration of autoclaved cercarial vaccine [ACV] that achieved the high percentage reduction of worm burden were safe as demonstrated by the absence of any local or systemic side effects, normal blood picture and normal liver and kidney function tests. ACV is stable when kept either at 4C for 6 months or at-35C for up to 12 months and it offers a considerable duration of longevity. The offspring of vaccinated mothers did not show any signs of protection against challenge infection